Yatharth Hospital & Trauma Care Services quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	393	258	+52.3%
EBITDA	91.7	64.5	+42.2%
EBITDA margin	23.4%	25.0%	−1.7 pts
Profit before tax	61.2	58.7	+4.3%
Net profit	45.4	42.0	+8.0%
EPS	₹4.88	₹4.36	+11.9%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023

Expenses
	393	342	320	279	258	232	219	218	212	178	167	171
	4.4	7.1	7.8	9.5	9.3	5.3	4.2	3.0	3.7	5.7	5.4	3.8
	397	349	328	289	267	237	223	221	215	183	172	175
	0.0	0.0	58.4	62.6	53.5	46.5	42.1	43.2	46.8	37.5	31.5	36.0
	71.1	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	−1.7	4.4	4.0	−6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	77.9	70.1	63.5	53.8	48.2	43.8	42.6	41.5	34.6	31.9	29.9	28.4
	6.6	5.1	1.0	0.3	0.2	1.0	2.1	1.6	2.9	0.4	0.2	2.9
	28.2	30.0	24.0	18.9	14.9	12.9	16.9	15.9	11.4	7.7	7.9	6.9
	154	129	120	105	91.6	84.4	79.6	78.5	76.7	61.9	58.9	61.3
	336	297	271	234	208	189	183	181	172	139	128	136
	91.7	79.9	74.2	64.5	64.5	57.0	54.9	54.6	53.7	46.5	46.4	45.6
	63.4	49.9	50.3	45.6	49.6	44.2	38.0	38.7	42.2	38.8	38.6	38.7
Profit
	61.2	52.0	57.1	54.8	58.7	48.5	40.2	40.1	43.0	44.1	43.8	39.6
	61.2	52.0	57.1	54.8	58.7	48.5	40.2	40.1	43.0	44.1	43.8	39.6
	15.7	11.3	15.1	12.3	14.6	13.8	11.2	10.6	13.6	4.3	14.0	11.7
	0.1	−4.1	−1.1	1.2	2.0	−3.9	−1.5	−1.5	−1.0	1.5	0.3	0.3
	15.8	7.3	14.0	13.6	16.6	9.8	9.7	9.1	12.6	5.8	14.3	12.0
	45.4	44.7	43.1	41.3	42.0	38.7	30.5	31.0	30.4	38.3	29.5	27.6
	45.4	44.7	43.1	41.3	42.0	38.7	30.5	31.0	30.4	38.3	29.5	27.6
	0.1	0.4	0.1	0.2	−0.2	0.2	0.2	−0.1	0.0	0.1	0.0	0.0
	45.6	45.1	43.2	41.4	41.9	38.9	30.7	30.8	30.4	38.5	29.5	27.6
	47.1	—	45.4	41.2	42.0	—	—	—	—	—	—	—
	−1.6	—	−2.3	0.0	0.0	0.0	—	—	0.0	—	—	—
Per share
	₹4.88	₹4.93	₹4.71	₹4.28	₹4.36	₹4.37	₹3.57	₹3.59	₹3.54	₹4.85	₹3.83	₹3.80
	₹4.88	₹4.93	₹4.71	₹4.28	₹4.36	₹4.37	₹3.57	₹3.59	₹3.54	₹4.85	₹3.83	₹3.80
Other comprehensive income — detail
	0.1	0.4	0.1	0.2	−0.2	0.2	—	—	—	—	—	—
	0.1	0.6	0.2	0.3	−0.2	0.3	0.2	−0.1	—	—	—	—
	0.0	0.1	0.0	0.1	−0.1	0.1	—	—	—	—	—	—
	—	—	—	—	—	—	0.1	−0.0	0.0	—	0.0	—
	47.2	—	45.5	41.4	41.9	38.9	—	—	—	—	—	—
	−1.6	—	−2.3	0.0	0.0	0.0	—	—	—	—	—	—
Per share — as-filed variants
	₹4.88	₹4.93	₹4.71	₹4.28	₹4.36	₹4.37	₹3.57	₹3.59	₹3.54	₹4.85	₹3.83	₹3.80
	₹4.88	₹4.93	₹4.71	₹4.28	₹4.36	₹4.37	₹3.57	₹3.59	₹3.54	₹4.85	₹3.83	₹3.80
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	323	279	258	223	204	185	177	175	165	140	135	135
	82.3%	81.8%	80.5%	79.8%	79.2%	79.9%	80.8%	80.2%	77.9%	78.9%	81.1%	79.0%
Adjusted (ex-exceptional items) — derived
	61.2	52.0	57.1	54.8	58.7	48.5	40.2	40.1	43.0	44.1	43.8	39.6
	45.4	44.7	43.1	41.3	42.0	38.7	30.5	31.0	30.4	38.3	29.5	27.6
	₹4.88	₹4.93	₹4.71	₹4.28	₹4.36	₹4.37	₹3.57	₹3.59	₹3.54	₹4.85	₹3.83	₹3.80

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

YATHARTH₹945.50

Yatharth Hospital & Trauma Care Services Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersMAXHEALTH MEDANTA FORTIS VIYASH THYROCARE SUPRIYA STAR SPARCMcap ₹9,110 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	171.3	166.8	177.8	211.8	217.8	219.2	231.8	257.8	279.4	320.5	341.6	392.7
Other Income	3.8	5.4	5.7	3.7	3.0	4.2	5.3	9.3	9.5	7.8	7.1	4.4
Total Income	175.1	172.2	183.4	215.4	220.7	223.4	237.1	267.1	288.9	328.3	348.7	397.0
Expenses
+ Cost of Materials Consumed	36.0	31.5	37.5	46.8	43.2	42.1	46.5	53.5	62.6	58.4	0.0	0.0
+ Purchases of Stock-in-Trade	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	71.1
+ Changes in Inventories	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-6.2	4.0	4.4	-1.7
+ Employee Benefit Expense	28.4	29.9	31.9	34.6	41.5	42.6	43.8	48.2	53.8	63.5	70.1	77.9
+ Finance Costs	2.9	0.2	0.4	2.9	1.6	2.1	1.0	0.2	0.3	1.0	5.1	6.6
+ Depreciation & Amortisation	6.9	7.9	7.7	11.4	15.9	16.9	12.9	14.9	18.9	24.0	30.0	28.2
+ Other Expenses	61.3	58.9	61.9	76.7	78.5	79.6	84.4	91.6	104.7	120.2	129.4	153.7
Total Expenses	135.5	128.4	139.3	172.5	180.6	183.2	188.6	208.4	234.1	271.2	296.7	335.8
EBITDA	45.6	46.4	46.5	53.7	54.6	54.9	57.0	64.5	64.5	74.2	79.9	91.7
EBIT	38.7	38.6	38.8	42.2	38.7	38.0	44.2	49.6	45.6	50.3	49.9	63.4
Profit
PBT before Exceptional Items	39.6	43.8	44.1	43.0	40.1	40.2	48.5	58.7	54.8	57.1	52.0	61.2
Pretax Income	39.6	43.8	44.1	43.0	40.1	40.2	48.5	58.7	54.8	57.1	52.0	61.2
+ Current Tax	11.7	14.0	4.3	13.6	10.6	11.2	13.8	14.6	12.3	15.1	11.3	15.7
+ Deferred Tax	0.3	0.3	1.5	-1.0	-1.5	-1.5	-3.9	2.0	1.2	-1.1	-4.1	0.1
Tax Expense	12.0	14.3	5.8	12.6	9.1	9.7	9.8	16.6	13.6	14.0	7.3	15.8
Net Income	27.6	29.5	38.3	30.4	31.0	30.5	38.7	42.0	41.3	43.1	44.7	45.4
+ Net Income — Continuing Ops	27.6	29.5	38.3	30.4	31.0	30.5	38.7	42.0	41.3	43.1	44.7	45.4
+ Other Comprehensive Income	0.0	0.0	0.1	0.0	-0.1	0.2	0.2	-0.2	0.2	0.1	0.4	0.1
Total Comprehensive Income	27.6	29.5	38.5	30.4	30.8	30.7	38.9	41.9	41.4	43.2	45.1	45.6
Net Income to Common	—	—	—	—	—	—	—	42.0	41.2	45.4	—	47.1
Minority Interest	—	—	—	0.0	—	—	0.0	0.0	0.0	-2.3	—	-1.6
Per Share
Basic EPS	3.80	3.83	4.85	3.54	3.59	3.57	4.37	4.36	4.28	4.71	4.93	4.88
Diluted EPS	3.80	3.83	4.85	3.54	3.59	3.57	4.37	4.36	4.28	4.71	4.93	4.88
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	0.2	-0.2	0.2	0.1	0.4	0.1
+ Items NOT to be Reclassified to P&L	—	—	—	—	-0.1	0.2	0.3	-0.2	0.3	0.2	0.6	0.1
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.1	-0.1	0.1	0.0	0.1	0.0
+ Tax on Items NOT to be Reclassified — alt tag	—	0.0	—	0.0	-0.0	0.1	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	—	—	—	—	—	—	38.9	41.9	41.4	45.5	—	47.2
Comprehensive Income — Non-controlling Interests	—	—	—	—	—	—	0.0	0.0	0.0	-2.3	—	-1.6
Per Share — as-filed variants
Basic EPS — Continuing Operations	3.80	3.83	4.85	3.54	3.59	3.57	4.37	4.36	4.28	4.71	4.93	4.88
Diluted EPS — Continuing Operations	3.80	3.83	4.85	3.54	3.59	3.57	4.37	4.36	4.28	4.71	4.93	4.88
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	135.2	135.3	140.3	165.0	174.6	177.1	185.3	204.3	223.0	258.0	279.4	323.3
Gross Margin %	78.95	81.10	78.92	77.90	80.18	80.81	79.94	79.24	79.82	80.51	81.80	82.34
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	39.6	43.8	44.1	43.0	40.1	40.2	48.5	58.7	54.8	57.1	52.0	61.2
Net Income Adj (tax-effected)	27.6	29.5	38.3	30.4	31.0	30.5	38.7	42.0	41.3	43.1	44.7	45.4
EPS Adj	3.80	3.83	4.85	3.54	3.59	3.57	4.37	4.36	4.28	4.71	4.93	4.88
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	—	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	—	—	—	—	—	—	96.4	96.4	96.4	96.4	96.4	96.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Yatharth Hospital & Trauma Care Services Q2 FY27 results date

Yatharth Hospital & Trauma Care Services (NSE: YATHARTH) will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, according to the board-meeting notice it filed on 26 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit attributable to shareholders was ₹47.1 crore, up 12.0% from ₹42 crore in Q1 FY26 and up 5.3% from ₹44.7 crore in Q4 FY26. Revenue from operations was ₹393 crore, up 52.3% year on year and up 15.0% from the previous quarter.

Board-meeting notice filed: 26 October 2026
Q1 FY27 results (the latest): 10 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 3 November 2026Tuesday · notice filed 26 Oct
Q1 FY27 net profit: ₹47.1 Cr+12.0% vs Q1 FY26+5.3% vs Q4 FY26
Q1 FY27 revenue: ₹393 Cr+52.3% vs Q1 FY26+15.0% vs Q4 FY26
Q1 FY27 operating margin: 16.2%−3.1 pts vs Q1 FY26+1.5 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹41.2 CrRevenue ₹279 Cr
Q1 FY27 EPS (basic): ₹4.88

Questions

When will Yatharth Hospital & Trauma Care Services announce its Q2 FY27 results?

On 3 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 26 October 2026).

What will Yatharth Hospital & Trauma Care Services' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit attributable to shareholders was ₹41.2 crore and revenue from operations ₹279 crore. The latest quarter, Q1 FY27, had a net profit of ₹47.1 crore and revenue of ₹393 crore.

What was Yatharth Hospital & Trauma Care Services' revenue in FY26?

Revenue from operations was ₹1,207 crore in FY26 (April 2025–March 2026), up 37.1% from ₹880 crore in FY25. It was ₹671 crore in FY24 and ₹372 crore in FY23: up 224.9% over three years, 48.1% a year on average.

What were Yatharth Hospital & Trauma Care Services' Q1 FY27 results?

Consolidated net profit attributable to shareholders was ₹47.1 crore, up 12.0% from ₹42 crore in Q1 FY26 and up 5.3% from ₹44.7 crore in Q4 FY26. Revenue from operations was ₹393 crore, up 52.3% year on year and up 15.0% from the previous quarter.

How has Yatharth Hospital & Trauma Care Services' profit changed over the last four quarters?

Net profit attributable to shareholders by quarter: ₹41.2 crore in Q2 FY26, ₹45.4 crore in Q3 FY26, ₹44.7 crore in Q4 FY26 and ₹47.1 crore in Q1 FY27. That is ₹178 crore over the four quarters, up 25.4% from ₹142 crore in the four quarters before. Revenue from operations: ₹279 crore, ₹320 crore, ₹342 crore and ₹393 crore.

What was Yatharth Hospital & Trauma Care Services' net profit in FY26?

Consolidated net profit attributable to shareholders was ₹170 crore in FY26 (April 2025–March 2026), up 30.5% from ₹131 crore in FY25. It was ₹114 crore in FY24 and ₹64.2 crore in FY23: up 165.4% over three years, 38.4% a year on average.

Where do these Yatharth Hospital & Trauma Care Services figures come from?

From Yatharth Hospital & Trauma Care Services' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.